| Nancy Jessica Lloyd, APRN | |
|
Sc House Calls Inc, 111 Doctors Circle, Columbia, SC 29203 | |
| (800) 491-0909 | |
| Not Available |
| Full Name | Nancy Jessica Lloyd |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | Sc House Calls Inc, Columbia, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164997003 | NPI | - | NPPES |
| NP5664 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 22148 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sc House Calls Inc | 6800994807 | 358 |
News Archive
Among individuals with a first episode of psychotic mania (FEPM), a longer duration of untreated psychosis may differentiate patients with schizoaffective disorder from those with bipolar I disorder, study results suggest.
In an effort to overcome the drug resistance that often occurs in cancer, a team of investigators has developed a nanoparticle made of a blend of polymers that first releases a powerful anticancer drug and then delivers an agent that tricks a drug-resistant cell into committing suicide. Now, tests in mice with human breast cancer have shown that these blended nanoparticles are effective in maintaining high levels of both drugs in the vicinity of tumors.
Opening a broad vista in the search for effective pharmaceuticals, a collaboration of Chinese and U.S. chemists has laid out a highly efficient new method to convert abundant organic molecules into new medicines.
Millennium, The Takeda Oncology Company today announced the publication of an article in the journal Blood describing the novel mechanism of action of MLN4924 through targeted pathway modulation in diffuse large B-cell lymphoma (DLBCL).
› Verified 2 days ago
| Entity Name | Sc House Calls Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518048859 PECOS PAC ID: 6800994807 Enrollment ID: O20070613000821 |
News Archive
Among individuals with a first episode of psychotic mania (FEPM), a longer duration of untreated psychosis may differentiate patients with schizoaffective disorder from those with bipolar I disorder, study results suggest.
In an effort to overcome the drug resistance that often occurs in cancer, a team of investigators has developed a nanoparticle made of a blend of polymers that first releases a powerful anticancer drug and then delivers an agent that tricks a drug-resistant cell into committing suicide. Now, tests in mice with human breast cancer have shown that these blended nanoparticles are effective in maintaining high levels of both drugs in the vicinity of tumors.
Opening a broad vista in the search for effective pharmaceuticals, a collaboration of Chinese and U.S. chemists has laid out a highly efficient new method to convert abundant organic molecules into new medicines.
Millennium, The Takeda Oncology Company today announced the publication of an article in the journal Blood describing the novel mechanism of action of MLN4924 through targeted pathway modulation in diffuse large B-cell lymphoma (DLBCL).
› Verified 2 days ago
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20191209002986 |
News Archive
Among individuals with a first episode of psychotic mania (FEPM), a longer duration of untreated psychosis may differentiate patients with schizoaffective disorder from those with bipolar I disorder, study results suggest.
In an effort to overcome the drug resistance that often occurs in cancer, a team of investigators has developed a nanoparticle made of a blend of polymers that first releases a powerful anticancer drug and then delivers an agent that tricks a drug-resistant cell into committing suicide. Now, tests in mice with human breast cancer have shown that these blended nanoparticles are effective in maintaining high levels of both drugs in the vicinity of tumors.
Opening a broad vista in the search for effective pharmaceuticals, a collaboration of Chinese and U.S. chemists has laid out a highly efficient new method to convert abundant organic molecules into new medicines.
Millennium, The Takeda Oncology Company today announced the publication of an article in the journal Blood describing the novel mechanism of action of MLN4924 through targeted pathway modulation in diffuse large B-cell lymphoma (DLBCL).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nancy Jessica Lloyd, APRN Sc House Calls Inc, 111 Doctors Circle, Columbia, SC 29203 Ph: (800) 491-0909 | Nancy Jessica Lloyd, APRN Sc House Calls Inc, 111 Doctors Circle, Columbia, SC 29203 Ph: (800) 491-0909 |
News Archive
Among individuals with a first episode of psychotic mania (FEPM), a longer duration of untreated psychosis may differentiate patients with schizoaffective disorder from those with bipolar I disorder, study results suggest.
In an effort to overcome the drug resistance that often occurs in cancer, a team of investigators has developed a nanoparticle made of a blend of polymers that first releases a powerful anticancer drug and then delivers an agent that tricks a drug-resistant cell into committing suicide. Now, tests in mice with human breast cancer have shown that these blended nanoparticles are effective in maintaining high levels of both drugs in the vicinity of tumors.
Opening a broad vista in the search for effective pharmaceuticals, a collaboration of Chinese and U.S. chemists has laid out a highly efficient new method to convert abundant organic molecules into new medicines.
Millennium, The Takeda Oncology Company today announced the publication of an article in the journal Blood describing the novel mechanism of action of MLN4924 through targeted pathway modulation in diffuse large B-cell lymphoma (DLBCL).
› Verified 2 days ago
Mr. Joseph Crawford Iii, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8 Richland Medical Park Dr Ste 300, Columbia, SC 29203 Phone: 803-256-6511 | |
Richard Hall Iii, APRN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Richland Medical Park Dr Ste 100, Columbia, SC 29203 Phone: 803-434-6095 Fax: 803-758-0120 | |
Latonya Brailsford, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4605 Monticello Rd Ste 2, Columbia, SC 29203 Phone: 803-753-5590 Fax: 803-753-5592 | |
Laketa D Riley, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 111 Doctor Cir, Columbia, SC 29203 Phone: 800-491-0909 | |
Jenny O'neill, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 200 Arbor Lake Dr, Suite 120, Columbia, SC 29223 Phone: 803-457-8125 Fax: 803-457-8129 | |
Sarah Elizabeth Wilson, PNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9 Richland Medical Park Dr Ste 420, Columbia, SC 29203 Phone: 803-434-3950 Fax: 803-434-3496 | |
Miss Karen Mccain, NURSE PRACTITONER Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 111 Doctor Cir, Columbia, SC 29203 Phone: 800-491-0909 |